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Abstract. Von Willebrand factor, tumor necrosis 
factor-α levels and portal bloodstream were examined in 47 
patients with liver cirrhosis and 8 apparently healthy per-
sons. The increase of von Willebrand factor and tumor 
necrosis factor-α levels were found to lead to the develop-
ment of erosive-ulcerative lesions of gastric mucosa. The 
abnormalities of portal resistance, von Willebrand factor 
and TNF-α are interrelated data which play a certain role in 
occurrence of erosive-ulcerative lesions of gastric mucosa 
in patients with liver cirrhosis. 
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Introduction. Congestive phenomena in the 
vascular system in case of portal hypertension, espe-
cially pronounced in the microcirculation, hypoxia, 
stasis, erythrocyte aggregation, and endotoxemia 
result in disorders of the erythrocyte morphofunc-
tional properties in liver cirrhosis patients and vascu-
lopathy [8]. The vascular intima of these patients is 
considerably injured, epithelial desquamation, bare 
and swollen basal membrane, neutrophil and fibro-
blast infiltration, parietal clot formation are found [2, 
7]. Endothelial cells lesion leads to von Willebrand-
factor (vWF) release – a multimeric glycoprotein 
participating in platelet adhesion and aggregation, 
promoting formation of microclots and further dis-
turbance of microcirculation [6].  
Intensified release of vWF in vitro is observed 
under the action of various stimuli including me-
chanical injury, endotoxins, histamine, complement 
complex as well as cytokines [4].  
Tumor necrosis factor-α (TNF-α) is a multi-
functional cytokine with a pronounced pleiotropy, 
produced by macrophages, lymphocytes, and playing 
a key role in the development of local and general 
systemic pathological processes.TNF-α regulates the 
intensity of inflammation, immune response, pos-
sessing hepatotoxic, pyrogenic effects etc. Increased 
TNF-α production promotes inhibition of the vascu-
lar smooth muscles reaction to restricting stimuli, 
causing hypoxia and sludge-phenomenon, intensify-
ing local and systemic microcirculatory disorders, 
activating inflammatory process. Besides, TNF-α 
level increase results in disturbance of mitochondrial 
respiration and apoptosis stimulation [5]. 
The purpose of the work is to detect a patho-
genetic role of von Willebrand factor, TNF-α, portal 
vein resistance in the development of lesions of the 
gastric mucus (GM) in patients with liver cirrhosis 
(LC).  
Materials and methods. 47 LC patients were 
examined. They were divided into three groups de-
pending on the character of GM lesions: the 1st group 
– LC patients without portal hypertensive gastropa-
thy (PHG) and erosive-ulcerous gastric lesions 
(EUGL) (8 individuals), the 2nd group – LC patients 
with PHG without EUGL (20 individuals), the 3rd 
group – LC patients with EUGL against the ground 
of PHG (19 individuals). A comparative group con-
tained 8 practically healthy individuals of corre-
sponding age and sex. 
TNF-α and vWF content in the blood plasma 
was detected by means of ELISA using the set of re-
agents “Shild Diagnostics” (Great Britain) and 
“Diaclone” (France) respectively. Doppler examina-
tion of the blood flow in the portal vein was carried 
out in the morning on empty stomach. The portal vein 
was visualized in the way that the angle between the 
vessel and detector was less than 600. The rate of 
blood flow and the diameter of the portal vein were 
measured during expiration for 2-3 seconds. The 
analysis of Doppler curve evaluated congestive index 
(CI), characterizing the resistance to portal blood flow 
by means of F.Moriyasu et al method [3]. For visual 
monitoring changes of gastric mucosa, all patients 
performed upper endoscopy using endoscope 
"Olimpus" (Japan). Mathematical analysis of the data 
was performed on a computer with a processor AMD 
Athlon 64 via licensing program Primer of Biostatis-
tics. Version 4.03 (S.Glantz, USA) to calculate the 
average value, the average error and students criteria. 
Critical significance level when testing statistical hy-
potheses in this study considered equal to 0,05. 
Results and discussion. The analysis of the re-
sults of the research showed that vWF increase in the 
blood plasma was observed in all the LC patients: in 
the 1st group of patients up to 10,94±1,55 IU/ml 
(р<0,05), the 2nd group – up to 16,99±2,07 IU/ml 
(р<0,01), the 3rd group – up to 18,37±2,31 IU/ml 
(р<0,01), as compared with PHI (4,76±1,70 IU/ml). A 
clear tendency to the increase of the given index with 
progressing lesions of GM with a reliable difference 
between the indices in the 3rd group of patients in 
comparison with the 1st one (p<0,05) was found. 
The analysis of portal vein resistance showed 
that CI increased in all patients with liver cirrhosis: in 
the 1st group of patients up to 0,055±0,005 (р>0,05), 
the 2nd group – up to 0,11±0,01 (р<0,01), the 3rd 
group – up to 0,22±0,02 (р<0,01). Normal data of CI 
was 0,03±0,003 in group of healthy people.  
The detected direct correlation between vWF 
and CI (r=0,71, р<0,01) is indicative of the role of 
endothelial lesion in the pathogenesis of portal circu-
lation disorders in case of LC. 
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vWF stimulating the formation of microclots 
and the progress of microcirculation disorders is 
likely to play a certain role in progressing of portal 
hypertension and occurring EUGL in LC patients.  
In addition, we have established that increase of 
TNF-α level in the blood plasma is found in all the 
LC patients as compared with PHI (10,96±1,69 pg/
ml): in the 1st group – up to 20,48±4,00 pg/ml 
(р<0,05), in the 2nd group – up to 34,22±6,16 pg/ml 
(р<0,001), in the 3rd group – up to 59,34±9,27 pg/ml 
(р<0,001), with a reliable difference of indices in the 
3rd group as compared with other groups (р<0,05-
0,01). 
Thus, a maximal value of TNF-α level in the 
blood plasma was in the 3rd group of patients which 
is indicative of its possible role in the pathogenesis 
of EUGL in LC patients. 
In addition, the conducted correlation-regressive 
analysis of the 3rd group of patients indicated that 
TNF-α in LC patients is one of the important factors 
of portal circulation disorders and endothelial le-
sions, which is proved by close correlation relations 
between the content of this cytokine in the blood 
plasma and Doppler findings of the portal circulation 
(TNF-α - CI, r=0,731, р<0,001), the level of vWF in 
the blood plasma (TNF-α-vWF, r=0,554, р<0,05).  
Experimental studies showed that TNF-α pro-
motes the activation of stellate cells, increased pro-
duction of the hepatic-cellular matrix (HCM) pro-
teins, inhibits apoptosis of the activated stellate cells 
[2], stimulates NOS and induces production of the 
blood plasma NO [1, 8]. Probably due to these 
mechanisms TNF-α in case of a considerable in-
crease of its concentration in the blood plasma of 
patients with LC and EUGL results in intensified 
intrahepatic vascular resistance and deterioration of 
Doppler findings of the portal circulation.  
At the same time, increased disorders of portal 
hemodynamics and catabolic properties of TNF-α 
cause the occurrence of vasculopathy and endothelial 
lesions, vWF increased level, formation of micro-
clots, promoting further deterioration of microcircu-
lation and progressing of GM lesions. 
Conclusions 
1. The patients with liver cirrhosis and erosive-
ulcerous gastric lesions detect a reliable increase of 
von Willebrand factor which is indicative of endo-
thelial lesions and progressing of microcirculatory 
disorders in such patients. 
2. Maximal violation of portal blood flow 
(increased congestive index) is found in patients with 
erosive and ulcerative lesions of the stomach and 
PHG. 
3. Tumor necrosis factor-α can be considered as 
one of the important mediators of portal circulative 
disorders, endothelial lesions and occurrence of ero-
sive-ulcerous lesions of the gastric mucus in patients 
with liver cirrhosis.  
Prospects for further research in this area are 
to improve methods of treatment of lesions of the 
gastric mucosa in patients with liver cirrhosis by 
correction of detected disturbances. 
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НЕКОТОРЫЕ АСПЕКТЫ ПАТОГЕНЕЗА ЭРОЗИВНО-ЯЗВЕННЫХ ПОРАЖЕНИЙ  
ЖЕЛУДКА У БОЛЬНЫХ ЦИРРОЗОМ ПЕЧЕНИ 
Н.М. Палиброда, А.И. Федив  
Резюме. Фактор Виллебранда (ФВ), фактор некроза опухолей-α (TNF-α) и портальный кровоток были иссле-
дованы у 47 пациентов с циррозом печени и поражениями желудка (портальная гипертензивная гастропатия, эрози-
вно-язвенные поражения желудка – ЭЯПЖ). Анализ результатов исследования показал, что уровень ФВ, TNF-α в 
плазме крови и индекс обструкции, который отображает сопротивление портальному кровотоку, возрастал с про-
грессированием поражений желудка, достигая максимальных значений у пациентов с ЭЯПЖ. Обнаружена прямая 
корреляционная связь между ФВ, TNF-α и индексом обструкции в воротной вене: ФВ–ИО, r=0,71 (р=0,01), TNF-α–
ИО, r=0,731 (р=0,001), TNF-α–ФВ, r=0,554 (р=0,04). Таким образом, ФВ, способствуя микротромбообразованию и 
прогрессированию нарушений микроциркуляции, вероятно играет роль в прогрессировании портальной гипертен-
зии и возникновении ЭЯПЖ у больных циррозом печени. TNF-α, как известно, способствует активации звездчатых 
клеток, продуцированию белков печеночного матрикса, приводит к усилению внутрипеченочного сосудистого 
сопротивления. Вместе с тем, рост нарушений портальной гемодинамики и катаболические свойства TNF-α обус-
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ловливают повреждение эндотелия, повышение уровня ФВ и ухудшение микроцикуляции, что в свою очередь при-
водит к прогрессированию поражений желудка вплоть до возникновения эрозий и гепатогенных язв. 
Ключевые слова: цирроз печени, эрозивно-язвенные поражения желудка, фактор Виллебранда, TNF-α, ин-
декс обструкции. 
ДЕЯКІ АСПЕКТИ ПАТОГЕНЕЗУ ЕРОЗИВНО-ВИРАЗКОВИХ УРАЖЕНЬ ШЛУНКА  
У ХВОРИХ НА ЦИРОЗ ПЕЧІНКИ  
Н.М. Паліброда, О.І. Федів  
Резюме. Фактор Віллебранда (ФВ), фактор некрозу пухлин-α (TNF-α) і портальний кровообіг були досліджені 
в 47 пацієнтів із цирозом печінки та ураженнями шлунка (портальна гіпертензивна гастропатія, ерозивно-виразкові 
ураження шлунка – ЕВУШ). Аналіз результатів дослідження показав, що рівень ФВ, TNF-α у плазмі крові та індекс 
обструкції, який характеризує опір портальному кровотоку, зростали із прогресуванням уражень шлунка, сягаючи 
максимальних значень у пацієнтів з ЕВУШ. Виявлений прямий кореляційний зв’язок між ФВ, TNF-α та індексом 
обструкції у ворітній вені: ФВ–ІО, r=0,71 (р=0,01), TNF-α–ІО, r=0,731 (р=0,001), TNF-α–ФВ, r=0,554 (р=0,04). Та-
ким чином, ФВ, сприяючи мікротромбоутворенню та порушенню мікроциркуляції, ймовірно відіграє роль у про-
гресуванні гіпертензії у системі ворітної вени. TNF-α, як відомо, сприяє активації зірчастих клітин, продукуванню 
білків печінкового матриксу, призводить до посилення внутрішньопечінкового судинного опору. Разом з тим пато-
логічні зміни портальної гемодинаміки та катаболічні властивості TNF-α зумовлюють пошкодження ендотелію, 
підвищення рівня ФВ та погіршення мікроцикуляції. Загалом, зростання показників ФВ, TNF-α у плазмі крові та 
прогресування портальної гіпертензії створюють передумови для розвитку уражень шлунка аж до виникнення еро-
зій та гепатогенних виразок.  
Ключові слова: цироз печінки, ерозивно-виразкові ураження шлунка, фактор Віллебранда, TNF-α, індекс 
обструкції. 
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